<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref146">
 <mixed-citation publication-type="book">
  <person-group person-group-type="author">
   <name>
    <surname>Toovey</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Griffin</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Lau</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Elliot</surname>
    <given-names>S.</given-names>
   </name>
  </person-group> (
  <year>2015</year>). “
  <article-title>Safety and pharmacokinetics in healthy volunteers of the anti-RSV antiviral AK0529</article-title>” in 
  <source>1st international meeting on respiratory pathogens, September 3th, Singapore.</source>
  <publisher-name>International Society for Influenza and other Respiratory Virus Diseases (ISIRV).</publisher-name>
 </mixed-citation>
</ref>
